Netflix’s No Good Deed has brought a unique twist to the medical drama genre by blending dark comedy with a deep dive into the rare disease sarcoidosis. The show, which stars O-T Fagbenle as Dennis, ...

Please provide your email address to receive an email when new articles are posted on . A greater proportion of patients receiving efzofitimod vs. placebo were steroid-free with a stable/improved King ...

Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosis Further development of namilumab for the treatment of sarcoidosis will be discontinued Primary Endpoint Details: ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Michelle M.

A research project supported by the National Institutes of Health has developed a tool to rapidly and inexpensively diagnose sarcoidosis, a chronic inflammatory disease marked by the growth of tiny ...

Sarcoidosis is a multi-systemic disease of unknown etiology with a clinical presentation ranging from asymptomatic disease to organ failure. While some patients with sarcoidosis have spontaneous ...

Cardiovascular magnetic resonance (CMR) imaging may help physicians make decisions about which patients with suspected cardiac sarcoidosis require an implantable cardioverter-defibrillator (ICD) to ...

Dr. Gilotra and Dr. Lin were each awarded $100k through FSR’s Cardiac Sarcoidosis Grant program, and Dr. Kahlmann and Dr.

For initial treatment of symptomatic pulmonary sarcoidosis, methotrexate appeared to work as well as prednisone over 24 weeks, the randomized PREDMETH trial showed. Mean change from baseline in the ...

According to the FSR, sarcoidosis is a rare inflammatory disease characterized by the formation of granulomas predominately in the lungs and, to a lesser extent, in other organs of the body. Despite ...

Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up. Test-retest repeatability for ...

The Foundation for Sarcoidosis Research (FSR) proudly announces the addition of seven new institutions to its growing FSR Global Sarcoidosis Clinic Alliance (FSR-GSCA): University of Chicago Medicine, ...